Cargando…
Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development
Hsa-miRNA-326 (miR-326) has recently been discovered having anticancer efficacy in different organs. However, the role of miR-326 on non-small cell lung cancer (NSCLC) is still ambiguous. In this study, we investigated the role of miR-326 on the development of NSCLC. The results indicated that miR-3...
Autores principales: | Sun, Chengcao, Huang, Chuanfeng, Li, Shujun, Yang, Cuili, Xi, Yongyong, Wang, Liang, Zhang, Feng, Fu, Yunfeng, Li, Dejia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884997/ https://www.ncbi.nlm.nih.gov/pubmed/26840018 http://dx.doi.org/10.18632/oncotarget.7071 |
Ejemplares similares
-
Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met
por: Sun, Chengcao, et al.
Publicado: (2015) -
Retraction: Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met
por: Sun, Chengcao, et al.
Publicado: (2023) -
Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway
por: Sun, Chengcao, et al.
Publicado: (2016) -
hsa_circ_0139402 Promotes Bladder Cancer Progression by Regulating hsa-miR-326/PAX8 Signaling
por: Wei, Bo, et al.
Publicado: (2022) -
Hsa_circ_0003998 Promotes Chemoresistance via Modulation of miR-326 in Lung Adenocarcinoma Cells
por: Yu, Wanjun, et al.
Publicado: (2019)